Drug Policy Alliance
The leading drug policy reform organization in the US, whose broader decriminalization work has created the political environment that has made state psilocybin reforms possible.
Type: advocacy
Location: New York, NY (National)
Membership: Open — donor and supporter membership
Venues: State legislative campaigns, federal advocacy
Activities: Drug decriminalization advocacy, harm reduction policy, expungement campaigns, ballot initiatives
About
The Drug Policy Alliance (DPA) is the nation's leading organization working to end the war on drugs. Founded by Ethan Nadelmann, it has worked for three decades on cannabis legalization, drug decriminalization, harm reduction infrastructure, and criminal justice reform.
While DPA is not primarily a psychedelic organization, its work is directly relevant to the psilocybin space: the political and legal frameworks that have enabled Oregon Measure 109, Colorado Proposition 122, and municipal decriminalization campaigns rest on infrastructure that DPA and allied organizations built. The broader public understanding that drug policy can be reformed — that scheduling decisions can change — owes much to cannabis legalization campaigns that DPA helped win.
DPA has explicitly supported psilocybin decriminalization and has published policy analysis on psychedelic reform.
Why It Matters
The political path that made psilocybin reform possible was cleared largely by cannabis legalization work that DPA and allies drove. Understanding the policy landscape for psilocybin requires understanding the broader drug policy reform movement — of which DPA is the central institution.
State Legal Context
See current psilocybin laws in New York.